Quest Laboratories (NSE:QUESTLAB) ROCE %: 11.46% (As of Mar. 2026)


NSE:QUESTLAB Quest Laboratories Ltd NSE:QUESTLAB
44 GF Score
Price ₹98.05
! 8 Warning Signs
View Full Analysis

What is Quest Laboratories ROCE %?

Quest Laboratories NSE:QUESTLAB -1.56% 44 ROCE % is 11.46% as of Mar. 2026. GuruFocus rates NSE:QUESTLAB with a GF Score™ of 44/100. The stock has 8 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Quest Laboratories's annualized ROCE % for the quarter that ended in Mar. 2026 was 11.46%.

Quest Laboratories  (NSE:QUESTLAB) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Quest Laboratories ROCE % Related Terms

Quest Laboratories ROCE % Historical Data

* Premium members only.

The historical data trend for Quest Laboratories's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quest Laboratories ROCE % Chart

Quest Laboratories Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial 62.60 51.96 64.13 34.13 21.80

Quest Laboratories Quarterly Data
Mar21 Mar22 Mar23 Sep23 Dec23 Mar24 Mar25 Mar26
ROCE % Get a 7-Day Free Trial 0.00 40.12 46.25 26.85 11.46
NSE:QUESTLAB
44GF Score
Quest Laboratories Ltd NSE:QUESTLAB
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Quest Laboratories ROCE % Calculation

Quest Laboratories's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=199.603/( ( (1216.486 - 371.759) + (1111.504 - 125.167) )/ 2 )
=199.603/( (844.727+986.337)/ 2 )
=199.603/915.532
=21.80 %

Quest Laboratories's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Mar. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Mar. 2025 )(Q: Mar. 2026 )
=104.896/( ( (1216.486 - 371.759) + (1111.504 - 125.167) )/ 2 )
=104.896/( ( 844.727 + 986.337 )/ 2 )
=104.896/915.532
=11.46 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 11.46% mean?
Quest Laboratories (NSE:QUESTLAB) has a ROCE % of 11.46% as of Mar. 2026.
Is Quest Laboratories' ROCE % too high?
Quest Laboratories' current ROCE % is 11.46%. The Drug Manufacturers industry median ROCE % is 7.00. Quest Laboratories' value of 11.46% is 63.8% above this industry median. Overall, Quest Laboratories has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Quest Laboratories' ROCE % compare to LLY and JNJ?
Quest Laboratories' ROCE % of 11.46% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.00. Quest Laboratories' value of 11.46% is 63.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.00, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Quest Laboratories's current ROCE % of 11.46% is 63.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Quest Laboratories's current ROCE % is 11.46%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quest Laboratories stock overvalued right now?
Quest Laboratories (NSE:QUESTLAB) has a current ROCE % of 11.46%. The current ROCE % is 11.46% and 63.8% above the Drug Manufacturers industry median of 7.00. Quest Laboratories' overall GF Score™ is 44/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Quest Laboratories (NSE:QUESTLAB), the current ROCE % is 11.46% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Quest Laboratories Business Description

Address Sector III, Plot No. 45, Pithampur Industrial Area, Opposite Kissan Pipe Unit 4, District Dhar, Pithampur, Dhar, MP, IND, 454775
Quest Laboratories Ltd is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. It produces various products, comprising ethical drugs, generic drugs, and over-the-counter drugs, and is also available in various forms such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids, among others. The company operates in a single segment of Drugs and Chemicals.
44GF Score

Get the complete analysis for NSE:QUESTLAB

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹98.05
Price